Promising research from The University of Toledo suggests it might be possible to cure Type I diabetes by reprogramming a patient's own immune cells to heal the pancreas and restore the body's ability to make insulin.
Feb 7, 2022
1
6
In 2010, doctors treated Doug Olson's leukemia with an experimental gene therapy that transformed some of his blood cells into cancer killers. More than a decade later, there's no sign of cancer in his body.
Feb 6, 2022
0
2
Researchers at University Hospitals Seidman Cancer Center and Case Western Reserve University have developed a novel approach to chimeric antigen receptor (CAR) T-cell therapy for B-cell cancers that triples the targeted ...
Feb 2, 2022
0
87
In the summer of 2010, Bill Ludwig and Doug Olson were battling an insidious blood cancer called chronic lymphocytic leukemia (CLL). They'd both received numerous treatments, and as remaining options became scarce, they volunteered ...
Feb 2, 2022
0
51
A study by researchers in the College of Health and Life Sciences at Aston University and commissioned by Scrap Car Comparison has revealed that the inside of our cars have significantly higher levels of germs on them than ...
Feb 2, 2022
1
4
It is unlikely that a cancer-causing chemical inside your car can be dusted or wiped way, according to new UC Riverside research.
Jan 26, 2022
1
61
Despite high remission rates for patients treated with T cells that are supercharged in laboratories into elite cancer warriors, there is still a considerable population of patients who eventually relapse, their cancers invariably ...
Aberrant splicing of messenger RNAs encoding surface antigen CD22 leads to downregulation of this protein in pediatric B-lymphoblastic leukemia (B-ALL), rendering malignant cells resistant to the effects of CD22-directed ...
Jan 4, 2022
0
28
Immunotherapies called chimeric antigen receptor (CAR) T cells use genetically engineered versions of a patient's own immune cells to fight cancer. These treatments have energized cancer care, especially for people with certain ...
Dec 30, 2021
0
172
Newly designed chimeric antigen receptor (CAR) T-cells targeting the CD19 antigen are effective in treating adults and children with B-cell malignancies, especially when produced under place-of-care manufacturing which is ...
Dec 20, 2021
0
3
